Published in J Biol Stand on April 01, 1979
The single radial immunodiffusion assay highlights small antigenic differences among influenza virus hemagglutinins. J Clin Microbiol (1981) 0.79
Influenzavirus neuraminidase and neuraminidase-inhibition test procedures. Bull World Health Organ (1973) 10.70
Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature (1985) 6.01
Molecular mechanisms of variation in influenza viruses. Nature (1982) 5.54
The Hong Kong-68 influenza A2 variant. Lancet (1968) 5.25
The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75
Evidence for host-cell selection of influenza virus antigenic variants. Nature (1983) 4.24
The nucleotide sequence of poliovirus type 3 leon 12 a1b: comparison with poliovirus type 1. Nucleic Acids Res (1983) 4.06
Synthesis of methyl-mercury compounds by extracts of a methanogenic bacterium. Nature (1968) 4.01
Gene products that promote mRNA turnover in Saccharomyces cerevisiae. Mol Cell Biol (1992) 4.00
Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b. Proc Natl Acad Sci U S A (1984) 3.98
Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine. Virus Res (2004) 3.95
Single-radial-hemolysis: a new method for the assay of antibody to influenza haemagglutinin. Applications for diagnosis and seroepidemiologic surveillance of influenza. Bull World Health Organ (1975) 3.88
The polypeptide composition of influenza A viruses. Virology (1971) 3.79
A quantitative, single-radial-diffusion test for immunological studies with influenza virus. J Gen Virol (1972) 3.69
Location and primary structure of a major antigenic site for poliovirus neutralization. Nature (1983) 3.64
Sialic acid receptor specificity on erythrocytes affects detection of antibody to avian influenza haemagglutinin. J Med Virol (2003) 3.23
Characterization of the ribonucleoprotein and neuraminidase of influenza A viruses by immunodiffusion. J Gen Virol (1969) 3.11
Prevalence of antibody to current influenza viruses and effect of vaccination on antibody response. Br Med J (1972) 3.10
The receptor-binding and membrane-fusion properties of influenza virus variants selected using anti-haemagglutinin monoclonal antibodies. EMBO J (1987) 3.03
Predictors of future falls in Parkinson disease. Neurology (2010) 3.00
Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. J Virol (1989) 2.89
Characterization of virulent and avirulent A/chicken/Pennsylvania/83 influenza A viruses: potential role of defective interfering RNAs in nature. J Virol (1985) 2.75
Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs. Virology (1985) 2.71
Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines. J Hyg (Lond) (1971) 2.70
Protective effect of 1-adamantanamine hydrochloride on influenza A2 infections in the family environment: a controlled double-blind study. Lancet (1969) 2.66
Biological cycles for toxic elements in the environment. Science (1974) 2.62
Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus. Virology (1987) 2.58
Antibody responses to antigenic determinants of influenza virus hemagglutinin. I. Thymus dependence of antibody formation and thymus independence of immunological memory. J Exp Med (1974) 2.54
An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines. J Biol Stand (1977) 2.46
Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. Am J Pathol (2000) 2.41
The metabolism of protocatechuate by Pseudomonas testosteroni. Biochem J (1968) 2.41
Monoclonal antibodies which block cellular receptors of poliovirus. Virus Res (1984) 2.40
VEGF is major stimulator in model of choroidal neovascularization. Invest Ophthalmol Vis Sci (2000) 2.38
Genetics of L-proline utilization in Escherichia coli. J Bacteriol (1981) 2.37
Effect of rubella vaccination programme on serological status of young adults in United Kingdom. Lancet (1979) 2.31
The degradation of trans-ferulic acid by Pseudomonas acidovorans. Biochemistry (1970) 2.29
Proline transport and osmotic stress response in Escherichia coli K-12. J Bacteriol (1986) 2.29
Antibody responses to antigenic determinants of influenza virus hemagglutinin. II. Original antigenic sin: a bone marrow-derived lymphocyte memory phenomenon modulated by thymus-derived lymphocytes. J Exp Med (1974) 2.25
Symbiotic properties of C4-dicarboxylic acid transport mutants of Rhizobium leguminosarum. J Bacteriol (1983) 2.19
Segregation of antigenic and biological characteristics during influenza virus recombination. J Gen Virol (1972) 2.18
Circulation of influenza viruses and paramyxoviruses in waterfowl originating from two different areas of North America. Bull World Health Organ (1985) 2.18
Evidence for a new type-specific structural antigen of the influenza virus particle. J Gen Virol (1972) 2.17
Antibody against influenza A2 virus neuraminidase in human sera. J Hyg (Lond) (1969) 2.12
An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination. Vaccine (1994) 2.09
Oxybenzone oxidation following solar irradiation of skin: photoprotection versus antioxidant inactivation. J Invest Dermatol (1996) 2.07
Succinate transport in Rhizobium leguminosarum. J Bacteriol (1981) 2.04
Leucine transport in Escherichia coli. The resolution of multiple transport systems and their coupling to metabolic energy. J Biol Chem (1975) 2.02
Antigenic composition of recombinant virus strains produced from human and avian influenza A viruses. J Gen Virol (1969) 2.01
The polymerisation of dietary sugars by dental plaque. Caries Res (1967) 1.96
Proline porter II is activated by a hyperosmotic shift in both whole cells and membrane vesicles of Escherichia coli K12. J Biol Chem (1988) 1.95
An antigenic variant of the Hong Kong-68 influenza A 2 virus. J Hyg (Lond) (1971) 1.95
Isolation and sequencing of Escherichia coli gene proP reveals unusual structural features of the osmoregulatory proline/betaine transporter, ProP. J Mol Biol (1993) 1.94
The reaction of multihalogenated hydrocarbons with free and bound reduced vitamin B 12. Biochemistry (1968) 1.93
Related studies of a recombinant influenza-virus vaccine. I. Derivation and characterization of virus and vaccine. J Infect Dis (1971) 1.90
Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol (1991) 1.89
Mechanical properties of vesicles. II. A model for osmotic swelling and lysis. Biophys J (1993) 1.89
Biomethylation of toxic elements in the environment. Science (1977) 1.87
Serological epidemiological studies with influenza A viruses. J Hyg (Lond) (1965) 1.86
Formation of methane from serine by cell-free extracts of Methanobacillus omelianskii. J Biol Chem (1965) 1.85
The extracellular polysaccharide produced from sucrose by a cariogenic streptococcus. Arch Oral Biol (1966) 1.83
Immunological relationships between the neuraminidases of human and animal influenza viruses. Bull World Health Organ (1969) 1.82
Interactive MR-guided biopsy in an open-configuration MR imaging system. Radiology (1995) 1.79
Biochemistry and regulation of a second L-proline transport system in Salmonella typhimurium. J Bacteriol (1980) 1.77
Monoclonal antibodies specific for the Sabin vaccine strain of poliovirus 3. Lancet (1982) 1.76
Cimetidine and placebo in the treatment of benign gastric ulcer: a multicenter double blind study. Gastroenterology (1978) 1.75
Osmoadaptation by rhizosphere bacteria. Annu Rev Microbiol (1996) 1.74
Trials in man with live recombinants made from A/PR/8/34 (H0 N1) and wild H3 N2 influenza viruses. Lancet (1975) 1.74
Inhibition of influenza viruses in vitro and in vivo by 1-adamantanamine hydrochloride. Br J Exp Pathol (1965) 1.73
Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3. J Gen Virol (1985) 1.72
Reversion to neurovirulence of the live-attenuated Sabin type 3 oral poliovirus vaccine. Nucleic Acids Res (1984) 1.71
Two proline porters in Escherichia coli K-12. J Bacteriol (1983) 1.70
Antigenic variation in current influenza A viruses: evidence for a high frequency of antigenic 'drift' for the Hong Kong virus. Bull World Health Organ (1974) 1.68
Immunological and physicochemical studies of influenza matrix (M) polypeptides. Virology (1976) 1.66
The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection. J Hyg (Lond) (1979) 1.65
Kinetic and Mössbauer studies on the mechanism of protocatechuic acid 4,5-oxygenase. Biochemistry (1972) 1.64
Characterization of an inducible porter required for L-proline catabolism by Escherichia coli K12. Can J Biochem (1979) 1.60
Antigenic variation in current human type A influenza viruses: antigenic characteristics of the variants and their geographic distribution. Bull World Health Organ (1973) 1.60
Redesigned purification yields a fully functional PutA protein dimer from Escherichia coli. J Biol Chem (1992) 1.60
An investigation of some factors affecting cross-reactivation between influenza A viruses. J Gen Virol (1971) 1.59
The next influenza pandemic: lessons from Hong Kong, 1997. Emerg Infect Dis (1999) 1.58
In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. J Investig Dermatol Symp Proc (1999) 1.58
Neuraminidase in avin influenza A virus antigenically related to that of human A0 and A1 subtypes. Nature (1969) 1.56
Studies with antibody to the purified haemagglutinin of an influenza Ao virus. J Gen Virol (1970) 1.56
How do children tell? The disclosure process in child sexual abuse. Child Abuse Negl (1996) 1.55
Sequence analysis identifies the proline dehydrogenase and delta 1-pyrroline-5-carboxylate dehydrogenase domains of the multifunctional Escherichia coli PutA protein. J Mol Biol (1994) 1.52
Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients. Dermatology (1995) 1.51
Proline dehydrogenase from Escherichia coli K12. Properties of the membrane-associated enzyme. Eur J Biochem (1983) 1.50
Therapeutic effect of 1-adamantanamine hydrochloride in naturally occurring influenza A 2 -Hong Kong infection. A controlled double-blind study. Lancet (1971) 1.49
Reactogenicity and immunogenicity of inactivated influenza A (H1N1) virus vaccine in unprimed children. Report to the Medical Research Council Committee on influenza and other respiratory virus vaccines. J Biol Stand (1980) 1.48
Membrane association of proline dehydrogenase in Escherichia coli is redox dependent. Proc Natl Acad Sci U S A (1987) 1.48
Na+ (Li+)-proline cotransport in Escherichia coli. J Membr Biol (1985) 1.48
Antigenic analysis of influenza A virus surface antigens: considerations for the nomenclature of influenza virus. Brief review. Arch Virol (1980) 1.46
Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions. J Biol Stand (1979) 1.45